REQUEST A DEMO
Total
USD $0.00
Search more companies

Artromed I E R C Sas (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Artromed I E R C Sas Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Artromed I E R C Sas is based in Colombia. The head office is in Bogota D.C.. It operates in the Pharmaceutical Preparation Manufacturing sector. It was established on January 14, 2011. There are currently 5 (2024) people employed by Artromed I E R C Sas. The latest financial highlights indicate a net sales revenue increase of 1.33% in 2023. Over the same period, its total assets grew by 0.85%. In, 2023, the company’s net profit margin increased by 2.72%.

Headquarters
Cl 105 # 21 85 Ap 603
Bogota D.C.; Bogota D.C; Postal Code: 0819

Contact Details: Purchase the Artromed I E R C Sas report to view the information.

Basic Information
Total Employees:
Purchase the Artromed I E R C Sas report to view the information.
Outstanding Shares:
Purchase the Artromed I E R C Sas report to view the information.
Incorporation Date:
January 14, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Artromed I E R C Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
1.33%
Total operating revenue
1.33%
Operating profit (EBIT)
870.44%
Net Profit (Loss) for the Period
870.44%
Total assets
0.85%
Total equity
42.56%
Operating Profit Margin (ROS)
2.72%
Net Profit Margin
2.72%
Return on Equity (ROE)
23.95%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?